SLABÝ, Ondřej. Translational potential of microRNAs in oncology. In Annual Congress of the European Society for Translational Medicine (EUSTM). 2013.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Translational potential of microRNAs in oncology
Autoři SLABÝ, Ondřej.
Vydání Annual Congress of the European Society for Translational Medicine (EUSTM), 2013.
Další údaje
Originální jazyk angličtina
Typ výsledku Prezentace na konferencích
Obor 30200 3.2 Clinical medicine
Stát vydavatele Lucembursko
Utajení není předmětem státního či obchodního tajemství
Organizační jednotka Středoevropský technologický institut
Klíčová slova anglicky microRNA; translational medicine; oncology
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Petra Vychytilová, Ph.D., učo 211789. Změněno: 8. 11. 2013 10:46.
Anotace
MicroRNAs (miRNAs)are small non-coding RNAs 18-25 nt long that downregulate gene expression during various crucial cell processes such as apoptosis, differentiation and development. Changes in the expression profiles of miRNAs have been observed in a variety of human solid tumors and hematological malignancies. Functional studies indicate that miRNAs act as tumor suppressors and oncogenes and are involved in hallmarks of cancer. These findings significantly extend concept of molecular pathogenesis of cancer and have shown great potential for miRNAs as a novel class of therapeutic targets. Several investigations have also described the ability of miRNA expression profiles to predict prognosis and response to selected treatments in cancer patients and support diagnosis of origin among cancer of unknown primary site. MiRNAs occurrence has been repeatedly observed also in blood serum, plasma and urine, and miRNAs as novel minimally invasive biomarkers have indicated reasonable sensitivity for cancer detection.
VytisknoutZobrazeno: 17. 7. 2024 23:30